# Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

> **NCT00438178** · PHASE1 · COMPLETED · sponsor: **Gemin X** · enrollment: 44 (actual)

## Conditions studied

- Hematological Malignancies

## Interventions

- **DRUG:** Obatoclax mesylate (GX15-070MS)

## Key facts

- **NCT ID:** NCT00438178
- **Lead sponsor:** Gemin X
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-10
- **Final completion:** —
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00438178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00438178, "Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00438178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*